Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

Minapharm Pharmaceuticals

Minapharm Pharmaceuticals is a regional leading pharmaceutical company headquartered in Cairo, Egypt. Through its subsidiary Rhein-Minapharm Biogenetics it serves the development and manufacturing of therapeutic proteins using different eukaryotic expression systems (yeast and mammalian cell culture). A highly experienced team and strategic alliances with national as well as international partners of high reputation form the basis for offering premier therapeutic solutions to many patients. We believe that it is our primary responsibility to provide access to innovative medicine.
Minapharm's R&D department is currently developing processes for an impressive number of pipeline projects based on the single cell yeast Hansenula polymorpha as well as CHO cells as expression systems. An increasing number of bulk products is produced in Rhein-Minaparm's own production facility using state-of-the-art and innovative technologies. Final dosage forms are commercialized by Minapharm Pharmaceuticals in the MENA market. In 2010 Minapharm acquired Berlin based ProBioGen, a renowned Contract Development and Manufacturing Organization, strengthening Minapharm's ambitions in continuation and expansion of the biologics field.

Details


Adresse:
Minapharm Pharmaceuticals

El Bardissi Street, 2T Takseem Assmaa Fahmy Street 1
00001 Heliopolis/Cairo
Ägypten
Arbeitsgebiet:
Sonstige Tätigkeitsfelder
Expansion:
international
Mitarbeiteranzahl:
mehr als 500